Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFAST.L Share News (FAST)

  • There is currently no data for FAST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Barclays, Coca-Cola HBC, IHG...

Tue, 06th May 2014 13:26

Shares in Barclays fell following Tuesday's news of a fall in first-quarter profits, but brokers are advising investors to buy the shares on hopes that its turnaround plan will bear fruit.Barclays is cutting costs and slashing jobs in a shake-up to streamline the bank and has pledged to give more details of its plans on Thursday. Analyst Richard Hunter at broker Hargreaves Lansdown said the shares were likely to be volatile before Thursday's announcement, but added: "If some of the rumoured changes are implemented, resulting in a more streamlined and obviously profitable bank, the recent upgrade of the market consensus to a 'buy' will have been vindicated."There is much to like with bottling firm Coca-Cola HBC (CCH), according to Numis Securities, but not enough for the broker to take a positive stance ahead of the company's first-quarter update on May 16th.Numis has initiated coverage of the stock with a 'hold' rating and 1,428p target price. "Much to like here but it is pointless being bold as regards forecasts at this early stage of the year and with geopolitical uncertainties currently so prominent. For non-holders, a watching brief is best maintained for now," said Analyst Charles Pick.UBS has raised its forecasts for InterContinental Hotels Group (IHG) but downgraded its rating on the stock from 'buy' to 'neutral', saying it sees limited upside for the shares.The bank has lifted its price target for the stock from 2,200p to 2,225p. However, UBS said: "While we acknowledge the strong operational momentum we downgrade the shares from 'buy' to 'neutral' due to insufficient share price upside relative to our price target to support a 'buy' rating".Countrywide's shares look attractive at current levels following the estate agent chain's strong first-quarter results, according to Panmure Gordon, which maintained a 'buy' rating and 700p target price on the stock."If the first-quarter momentum is sustained or accelerated there is scope for earnings upgrades. The economy is getting stronger and real wages are picking up which is very supportive," the broker said.Cantor Fitzgerald has slashed its target price for AIM-listed Fastnet Oil & Gas after the company plugged and abandoned one of its wells offshore Morocco."In terms of valuation, we increase our overall risking of Moroccan frontier acreage, especially following Cairns unsuccessful well in December 2013. On this basis, whilst we anticipate an initial sell-down this morning, we retain our 'buy' recommendation, reducing our target price to 19p (from 28p)."BC
More News
11 Apr 2016 15:04

AGM, EGM Calendar - Week Ahead

Read more
31 Mar 2016 09:33

WINNERS & LOSERS SUMMARY: AO World Surges On Strong Fourth Quarter

Read more
31 Mar 2016 09:21

Orphan drug specialist Amryt Pharma to reverse into AIM's Fastnet

(ShareCast News) - Headed by Shire founder Harry Stratford as its chairman, speciality drug company Amryt Pharmaceuticals has confirmed its plan to reverse into AIM-listed Fastnet, raise £10m and acquire two drug developing businesses. Following a capital reorganisation planned for 18 April, the rev

Read more
31 Mar 2016 07:41

Fastnet Equity To Become Amryt Pharma After Reverse Takeover (ALLISS)

Read more
22 Feb 2016 10:33

CORRECT: Fastnet In Talks For Reverse Takeover Of Amryt Pharma (ALLISS)

Read more
22 Feb 2016 08:56

Fastnet Equity In Talks For Reverse Takeover Of Amryt Pharma (ALLISS)

Read more
22 Feb 2016 08:42

Fastnet Equity in talks to acquire Amryt Pharmaceuticals  

(ShareCast News) - Fastnet Equity shares have been suspended from trading after it said it is in advanced discussions for a reverse takeover of Amryt Pharmaceuticals. The AIM-listed company said on Monday if the acquisition proceeds, the enlarged group will become a late stage, specialty biopharmace

Read more
21 Dec 2015 14:20

Fastnet Equity Names Shire Founder Harry Stratford To Board

Read more
18 Dec 2015 11:41

Fastnet Spins Off Energy Assets As It Transitions Into Healthcare

Read more
23 Sep 2015 15:06

AGM, EGM Calendar - Week Ahead

Read more
4 Sep 2015 08:39

Fastnet Eyes Healthcare Industry Investment Opportunities

Read more
28 Aug 2015 07:15

LONDON BRIEFING: Tesla Deal Electrifies Rare Earth And Bacanora Shares

Read more
28 Aug 2015 05:32

AGM, EGM Calendar - Week Ahead

Read more
27 Aug 2015 15:27

AGM, EGM Calendar - Week Ahead

Read more
27 Aug 2015 05:15

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.